Ligand validation:6LGO

EBO: (2~{S})-2-azanyl-4-[(3~{S})-3-[(~{E})-[2-methyl-3-oxidanyl-5-(phosphonomethyl)pyridin-4-yl]methylideneamino]-4-oxidanyl-4-oxidanylidene-butyl]sulfanyl-butanoic acid

EBO is a Ligand Of Interest in 6LGO designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6LGO_EBO_D_501	87%	1%	0.101	0.975	2.45	5.18	10	21	0	0	100%	1
6LGO_EBO_C_501	84%	2%	0.115	0.976	2.79	4.64	12	17	0	0	100%	1
6LGO_EBO_B_501	81%	1%	0.116	0.97	3.39	4.79	14	19	0	0	100%	1
6LGO_EBO_A_501	79%	1%	0.122	0.969	2.91	4.85	13	21	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.